U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT06943794) titled 'Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk' on March 20.
Brief Summary: This study is a prospective, multicenter randomized controlled study. Additional fecal screening for Hp-specific SNP mutation sites on top of routine Hp testing may improve the identification of people at high risk for gastric cancer, and the treatment of eradication interventions in high-risk groups can significantly reduce the incidence or risk of progression of gastric cancer.
Study Start Date: May 01
Study Type: INTERVENTIONAL
Condition:
Gastric (Stomach) Cancer
Intervention:
DRUG: recommendations for eradication treatment...